Legend Biotech Hires New Leader
Legend Biotech named Ingrid Zhang as its new CEO, bringing fresh leadership from Novartis to grow its cancer treatments.
A big change is happening at Legend Biotech. The company just named a new leader. Ingrid Zhang is now the Chief Executive Officer. She comes from Novartis, another major drug company.
Legend Biotech makes special cancer treatments. These treatments are called CAR-T therapies. They help people fight cancer. The company wants to grow and help more patients. Ms. Zhang will help Legend Biotech reach more doctors and patients.
This news comes after the last CEO, Ying Huang, left in July. Now, Legend Biotech has a new plan. Ms. Zhang's experience from Novartis will help guide the company's next steps. She will focus on making sure their cancer drugs get to those who need them.
Source: FierceBiotech
More from Biotech
